Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma

NCT01959438 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Malignant Tumor
Treatment Resistant Disorders
Tumor Progression

Interventions

DRUG: Sodium selenite (Introselen)
DRUG: Sodium selenite

Sponsor

Karolinska University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]